ELOCP31

Across TCGA pan-cancer cohorts, ELOCP31 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of ELOCP31’s most consistent transcriptional readouts.

The strongest signal is observed in cholangiocarcinoma (CHOL), where ELOCP31 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ELOCP31 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

CHOL, COAD, and LUAD are the cancer types where ELOCP31 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ELOCP31 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CHOL	All	II,III,IV	+0.385	<.001	4	view →
COAD	All	II,III,IV	+0.112	.016	4	view →
LUAD	All	All	+0.263	.009	2	view →
THCA	Female	All	−0.126	.004	2	view →
HNSC	Male	All	+0.080	.015	2	view →
STAD	All	All	+0.143	.023	1	view →
LIHC	All	All	+0.033	.012	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

ELOCP31–CHOL

Open the CHOL breakdown →